Jessica A Harfst

  • Citations Per Year
Learn More
BACKGROUND Oclacitinib (Apoquel(®) ) inhibits the function of a variety of pro-inflammatory, pro-allergic and pruritogenic cytokines that are dependent on Janus kinase enzyme activity. Oclacitinib selectively inhibits Janus kinase 1. HYPOTHESIS/OBJECTIVES We aimed to evaluate the safety and efficacy of oclacitinib for the control of pruritus associated(More)
  • 1